Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-12-000585
Filing Date
2012-11-07
Accepted
2012-11-07 17:32:44
Documents
2
Period of Report
2012-11-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 5379
2 POWER OF ATTORNEY FOR ALEXANDER CROSS cross091112atossageneticspoa.htm EX-24 9573
  Complete submission text file 0000904454-12-000585.txt   16366
Mailing Address C/O LIGAND PHARMACEUTICALS INC., 10275 SCIENCE CENTER DR. SAN DIEGO CA 92121
Business Address
CROSS ALEXANDER D (Reporting) CIK: 0001182619 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35610 | Film No.: 121187852

Mailing Address 4105 E MADISON STREET SUITE 320 SEATTLE WA 98112
Business Address 4105 E MADISON STREET SUITE 320 SEATTLE WA 98112 206 325 6086
ATOSSA GENETICS INC (Issuer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus